Cargando…

Lack of Carcinogenicity of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx) in Cynomolgus Monkeys

The carcinogenic potential of 2‐amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx) was evaluated in cynomolgus monkeys. The animals received MeIQx, beginning at the age of one year, at doses of 10 or 20 mg/kg body weight by gavage five times a week for 84 months and were autopsied 8 months thereaft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Kumiko, Tsuda, Hiroyuki, Shirai, Tomoyuki, Ogiso, Tadashi, Wakabayashi, Keiji, Dalgard, Dan W., Thorgeirsson, Unnur P., Thorgeirsson, Snorri S., Adamson, Richard H., Sugimura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1999
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926120/ https://www.ncbi.nlm.nih.gov/pubmed/10429653 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00792.x

Ejemplares similares

Down‐regulation of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx)‐induced CYP1A2 Expression Is Associated with Bovine Lactoferrin Inhibition of MeIQx‐induced Liver and Colon Carcinogenesis in Rats
por: Fujita, Ken‐ichi, et al.
Publicado: (2002)

Effects of Chlorophyll a and b in Reducing Genotoxicity of 2-Amino-3,8-dimethylimidazo[4,5-F]quinoxaline (MeIQx)
por: Kocaoğlu Cenkci, Serap, et al.
Publicado: (2022)

Carcinogenicity of 2‐Amino‐3‐methylimidazo[4,5‐f]quinoline in Nonhuman Primates: Induction of Tumors in Three Macaques
por: Adamson, Richard H., et al.
Publicado: (1990)

A modeling approach to evaluate the balance between bioactivation and detoxification of MeIQx in human hepatocytes
por: Delannée, Victorien, et al.
Publicado: (2017)

Formation and Removal of DNA Adducts in the Liver of Rats Chronically Fed the Food‐borne Carcinogen, 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline
por: Hirose, Misako, et al.
Publicado: (1995)

Hepatocellular Carcinoma Induction in LEC Rats by a Low Dose of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline
por: Sone, Hideko, et al.
Publicado: (1996)

Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine
por: Fukushima, Shoji, et al.
Publicado: (2002)

Ethanol Does Not Promote MeIQx-initiated Rat Colon Carcinogenesis Based on Evidence from Analysis of a Colon Cancer Surrogate Marker
por: Kushida, Masahiko, et al.
Publicado: (2009)

DNA Adducts Formed by 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline in Rat Liver: Dose‐Response on Chronic Administration
por: Yamashita, Katsumi, et al.
Publicado: (1990)

Lack of Hepatocarcinogenicity of Combinations of Low Doses of 2-amino-3, 8-dimethylimidazo[4,5- f ]quinoxaline and Diethylnitrosamine in Rats: Indication for the Existence of a Threshold for Genotoxic Carcinogens
por: Wei, Min, et al.
Publicado: (2012)

Dose‐dependent Induction of 8‐Hydroxyguanine and Preneoplastic Foci in Rat Liver by a Food‐derived Carcinogen, 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline, at Low Dose Levels
por: Kato, Toshio, et al.
Publicado: (1996)

p53 Gene Mutation in Hepatocellular Carcinoma Induced by 2‐Amino‐3‐methylimidazo[4,5‐f]quinoline in Nonhuman Primates
por: Fujimoto, Yoshinori, et al.
Publicado: (1994)

Chemical carcinogenesis studies in nonhuman primates
por: Takayama, Shozo, et al.
Publicado: (2008)

Induction of hepatocellular carcinoma in nonhuman primates by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline.
por: Adamson, R H, et al.
Publicado: (1994)

Inhibition of 2‐Amino‐3, 8‐dimethylimidazo[4,5‐f]quinoxaline‐mediated DNA‐adduct Formation by Chlorophyllin in Drosophila
por: Sugiyama, Chitose, et al.
Publicado: (1996)

Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo-[4,5-f]quinoline and 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring.
por: Turesky, R J, et al.
Publicado: (1993)

Mechanism of Oxidative DNA Damage Induced by a Heterocyclic Amine, 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline
por: Murata, Mariko, et al.
Publicado: (1999)

Effects of Chronic Administration of Low Doses of 2‐Ammo‐3,8‐dimethylimidazo‐[4,5‐f]qumoxaline on Glutathione S‐Transferase Placental Form‐positive Foci Development in the Livers of Rats Fed a Choline‐deficient Diet
por: Sone, Hideko, et al.
Publicado: (1993)

Carcinogenicity of food mutagens.
por: Sugimura, T, et al.
Publicado: (1996)

What Makes Cirrhosis Irreversible?—Consideration on Structural Changes
por: Dezső, Katalin, et al.
Publicado: (2022)

Genotoxicity of N-acetylarylamines in the Salmonella/hepatocyte system
por: Thorgeirsson, Snorri S., et al.
Publicado: (1983)

Testicular microlithiasis in a clinically healthy cynomolgus monkey (Macaca fascicularis)
por: Shirai, Norimitsu, et al.
Publicado: (2018)

Enhancement by Cigarette Smoke Exposure of 2‐Amino‐3,8‐dimethylimidazo[4,5‐ f]quinoxaline‐induced Rat Hepatocarcinogenesis in Close Association with Elevation of Hepatic CYP1A2
por: Nishikawa, Akiyoshi, et al.
Publicado: (2002)

Formation of 2‐Amino‐3‐methylimidazo[4,5‐f]quinoline‐ and 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline‐sulfamates by cDNA‐expressed Mammalian Phenol Sulfotransferases
por: Ozawa, Shogo, et al.
Publicado: (1995)

Keratoconus in a Cynomolgus Monkey
por: Kodama, Rinya, et al.
Publicado: (2010)

Erythrocytes of the Rhesus and Cynomolgus Monkeys
por: Stingo, Vincenzo
Publicado: (2019)

Difference in Target Organs in Carcinogenesis with a Heterocyclic Amine, 2‐Amino‐3,4‐dimethylimidazo[4,5‐f]quinoline, in Different Strains of Mice
por: Fujita, Hirofumi, et al.
Publicado: (1999)

Cardiac damage induced by 2-amino-3-methyl-imidazo[4,5-f]quinoline in nonhuman primates.
por: Thorgeirsson, U P, et al.
Publicado: (1994)

Bilateral Cataract in a Cynomolgus Monkey
por: Sasaki, Yuji, et al.
Publicado: (2011)

Acquired genetic and functional alterations associated with transforming growth factor β type I resistance in Hep3B human hepatocellular carcinoma cell line
por: Zimonjic, Drazen B, et al.
Publicado: (2009)

Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals.
por: Nagao, M, et al.
Publicado: (1996)

DLC-1:a Rho GTPase-activating protein and tumour suppressor
por: Durkin, Marian E, et al.
Publicado: (2007)

Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells
por: Li, Dandan, et al.
Publicado: (2018)

Origins of Cortical GABAergic Neurons in the Cynomolgus Monkey
por: Petanjek, Zdravko, et al.
Publicado: (2009)

Porencephaly in a Cynomolgus Monkey (Macaca Fascicularis)
por: Hirowatari, Chika, et al.
Publicado: (2012)

Bartonella quintana in Cynomolgus Monkey (Macaca fascicularis)
por: O'Rourke, Laurie G., et al.
Publicado: (2005)

Epigenetic Changes with Dietary Soy in Cynomolgus Monkeys
por: Howard, Timothy D., et al.
Publicado: (2011)

Characteristics of histologically confirmed endometriosis in cynomolgus monkeys
por: Nishimoto-Kakiuchi, A., et al.
Publicado: (2016)

Granulovacuolar Degeneration in Brains of Senile Cynomolgus Monkeys
por: Darusman, Huda S., et al.
Publicado: (2019)

Multiplex precise base editing in cynomolgus monkeys
por: Zhang, Wenhui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kasdlchp2ujgqq3iiskmnipd4i